Viewing Study NCT01229202

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-06-13 @ 5:59 PM
Study NCT ID: NCT01229202
Status: WITHDRAWN
Last Update Posted: 2024-08-21
First Post: 2010-10-25
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Use of Bevacizumab to Modulate the Outcomes of Trabeculectomy Surgery
Sponsor: Nova Scotia Health Authority
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glaucoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None trabeculectomy View
None glaucoma surgery View
None bevacizumab View
None Vascular Endothelial Growth Inhibitor View
None glaucoma View